| 发明名称 |
VITRONECTIN RECEPTOR ANTAGONIST PHARMACEUTICALS FOR USE IN COMBINATION THERAPY. |
| 摘要 |
<p>The present invention describes novel kits and compositions comprising compounds of the formula (I): (Q)d-Ln-Ch, useful for the diagnosis and treatment of cancer in combination therapy in a patient. The present invention provides novel compounds useful for the treatment of rheumatoid arthritis. The pharmaceuticals are comprised of a targeting moiety that binds to a receptor that is upregulated during angiogenesis, an optional linking group, and a therapeutically effective radioisotope or diagnostically effective imageable moiety.</p> |
| 申请公布号 |
MXPA02012750(A) |
申请公布日期 |
2004.07.30 |
| 申请号 |
MX2002PA12750 |
申请日期 |
2001.06.21 |
| 申请人 |
BRISTOL-MYERS SQUIBB PHARMA COMPANY. |
发明人 |
BARRETT, JOHN, A. |
| 分类号 |
C07H15/26;A61K31/138;A61K31/4164;A61K31/4196;A61K31/454;A61K31/4709;A61K31/53;A61K31/5377;A61K31/566;A61K31/569;A61K31/57;A61K31/58;A61K31/7052;A61K31/724;A61K38/00;A61K38/21;A61K38/24;A61K41/00;A61K45/00;A61K47/16;A61K47/26;A61K47/34;A61K47/40;A61K51/00;A61K51/04;A61P9/00;A61P35/00;A61P43/00;C07D401/14;C08B37/16;(IPC1-7):A61K41/00 |
主分类号 |
C07H15/26 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
